{
  "id": "602c1dc41cb411341a00011f",
  "type": "summary",
  "question": "What is bimagrumab",
  "ideal_answer": "Bimagrumab is a fully human monoclonal antibody that blocks the activin type II receptors, preventing the activity of myostatin and other negative skeletal muscle regulators.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/27167138",
    "http://www.ncbi.nlm.nih.gov/pubmed/29226558",
    "http://www.ncbi.nlm.nih.gov/pubmed/30095981",
    "http://www.ncbi.nlm.nih.gov/pubmed/29566437"
  ],
  "snippets": [
    {
      "text": "Bimagrumab is a fully human monoclonal antibody that blocks the activin type II receptors, preventing the activity of myostatin and other negative skeletal muscle regulators.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30095981",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Activin Type II Receptor Blockade for Treatment of Muscle Depletion in Chronic Obstructive Pulmonary Disease. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30095981",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Bimagrumab (BYM338) is a novel fully human monoclonal antibody that exerts strong promyogenic effects on skeletal muscle by blocking activin type II receptors (ActRII).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167138",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "RATIONALE: Bimagrumab is a fully human monoclonal antibody that blocks the activin type II receptors, preventing the activity of myostatin and other negative skeletal muscle regulators.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30095981",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: Bimagrumab is a human monoclonal antibody inhibitor of activin type II receptors (ActRII), with anabolic action on skeletal muscle mass by blocking binding of myostatin and other negative regulators of muscle growth.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29566437",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Bimagrumab is a human anti-ActRII antibody which was found to increase muscle mass and function by blocking ActRII signaling.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29226558",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}